|
Originally published In Press as doi:10.1074/jbc.M003177200 on April 21, 2000
J. Biol. Chem., Vol. 275, Issue 28, 21364-21371, July 14, 2000
Interferon- Induces Nmi-IFP35 Heterodimeric Complex Formation
That Is Affected by the Phosphorylation of IFP35*
Xiangjun
Zhou §,
Jian
Liao¶,
Anke
Meyerdierks ,
Li
Feng ,
Louie
Naumovski**,
Erik C.
Böttger , and
M. Bishr
Omary 
From the Palo Alto Veterans Affairs Medical Center
and Stanford University, Palo Alto, California 94304, the
Institut für Medizinische Mikrobiologie, Medizinische
Hochschule Hannover, 30625 Hannover, Germany, and the ** Department of
Pediatrics, Stanford University, Stanford, California 94305
Nmi and IFP35 are interferon (IFN)-induced
proteins. In cells treated with IFN- , Nmi enhances the association
of transcription co-activator CBP/p300 with signal transducer and
activator of transcription proteins, and IFP35 forms a high molecular
weight cytosolic complex of unknown constituents. Here we show that Nmi and IFP35 co-immunoprecipitate with an anti-keratin 19 antibody, which
is due to cross-reaction of the antibody with Nmi, and suggests an
Nmi-IFP35 physical association. In support of this, Nmi and IFP35
co-immunoprecipitate using anti-Nmi and anti-IFP35 antibodies, manifest enhanced colocalization as determined by immunofluorescence staining of IFN-treated cells, and form heterodimers as determined by
chemical cross-linking. Nmi and IFP35 are primarily cytosolic proteins,
and their interaction is increased after IFN- treatment of cells as
early as 1 h after exposure. Sucrose gradient sedimentation and
size fractionation showed a shift of Nmi-IFP35 heterodimers toward a
heavier fraction (100-200 kDa) in IFN- -treated cells. This dynamic
complex formation is reversed by pretreatment with okadaic acid.
Two-dimensional gel analysis indicates that the IFN-induced complex
formation correlates with IFP35 dephosphorylation. Our data demonstrate
Nmi-IFP35 cytosolic localization and heterodimerization, and an
IFN- -regulated molecular event in which Nmi and IFP35 participate,
reversibly and by a dephosphorylation dependent fashion, in a
100-200-kDa molecular complex formation.
*
This work was supported in part by Deutsche
Forschungsgemeinschaft Grant SFB 244 B9 (to E. C. B.), a
Veterans Affairs Career Development Award (to M. B. O.), and
National Institutes of Health Grant DK47918 (to M. B. O.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by Training Grant DK07056 (to Stanford University School
of Medicine). To whom reprint requests should be addressed.
¶
Current address: Clontech Laboratories, Palo Alto, CA 94303.

To whom all correspondence should be addressed: Palo Alto
Veterans Affairs Medical Center, 154J 3801 Miranda Ave., Palo Alto, CA
94304. Fax: 650-852-3259.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Li, T.-H. Lee, and H. Avraham
A Novel Tricomplex of BRCA1, Nmi, and c-Myc Inhibits c-Myc-induced Human Telomerase Reverse Transcriptase Gene (hTERT) Promoter Activity in Breast Cancer
J. Biol. Chem.,
May 31, 2002;
277(23):
20965 - 20973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, R. L. Shpall, A. Meyerdierks, M. Hagemeier, E. C. Bottger, and L. Naumovski
Interferon-inducible Myc/STAT-interacting Protein Nmi Associates with IFP 35 into a High Molecular Mass Complex and Inhibits Proteasome-mediated Degradation of IFP 35
J. Biol. Chem.,
November 10, 2000;
275(46):
36278 - 36284.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|